{"id":17203,"date":"2010-02-03T08:23:41","date_gmt":"2010-02-03T08:23:41","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=17203"},"modified":"2026-04-02T15:23:26","modified_gmt":"2026-04-02T15:23:26","slug":"roche-face-in-romania-peste-100-mil-euro-cu-doar-trei-medicamente","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=17203","title":{"rendered":"Roche face in Romania peste 100 mil. euro cu doar trei medicamente"},"content":{"rendered":"<p>Aceste medicamente sunt incluse in programe nationale, costul<br \/>\nlor fiind integral suportat de Casa de Asigurari de Sanatate.<\/p>\n<p>Roche a fost in 2009 liderul pietei farmaceutice, pozitie pe<br \/>\ncare in prezent a pierdut-o in urma preluarii Zentiva de catre<br \/>\nSanofi-Aventis.<\/p>\n<p>Cititi mai multe pe <a target=\"_blank\" href=\n\"http:\/\/www.zf.ro\/companii\/roche-face-peste-100-mil-euro-cu-trei-medicamente-vedeti-care-sunt-ele-5469438\/\"><br \/>\nwww.zf.ro<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neorecormon (insuficienta renala), Pagasys (hepatita) si Avastin (cancer), cele mai vandute medicamente din Romania si care apartin companiei elvetiene Roche, au cumulat anul trecut vanzari de circa 108 mil. euro, adica aproximativ 5,2% din piata farmaceutica, conform datelor companiei IMS Health.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[15656,8088,15654,15655,8623,7212],"class_list":["post-17203","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-avastin","tag-farma","tag-neorecormon","tag-pagasys","tag-roche","tag-vanzari"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/17203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17203"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/17203\/revisions"}],"predecessor-version":[{"id":37156,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/17203\/revisions\/37156"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}